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In previous publications experimental evidence has been adduced to show 
that vitamin C  (l-ascorbic acid) may play an important part in enhancing 
resistance to poliomyelitic infection in the monkey.  Not only could we 
demonstrate that ascorbic acid possesses powerful antiviral properties in 
vitro  (1),  but  the administration of  this  substance  to  monkeys infected 
intracerebraUy with the Aycock strain of poliomyelitis virus was followed 
by  a  milder  infection  than  was  observed  in  untreated  control  animals 
(2,  3).  However, the fact  could not be ignored that  marked variations 
occurred in individual response, owing presumably to dissimilar degrees of 
utilization  of  the  vitamin  (4).  Less  favorable  figures were  obtained  in 
another group of monkeys that had received synthetic ascorbic acid. 
In the further course of this work an attempt was made to study the 
effect of vitamin C  administration on experimental poliomyelitis induced 
by  nasal  instillation of  the virus  (RMV  strain).  What  appeared to  be 
encouraging results were obtained in two small series; however, because of 
the small number of animals and uncertainties in the technique of nasal 
instillation we refrained from drawing any conclusions from these prelimi- 
nary observations.  Meanwhile Sabin (5) has published data to show that 
in his tests vitamin C, either natural or synthetic, failed to exert any demon- 
strable effect on the course of experimental poliomyelitis induced by nasal 
instillation of the RMV strain of virus. 
Since the very beginning of this investigation it had been realized  that 
the measure of therapeutic success attainable by vitamin C administration 
depended upon certain variables  the operation of which was not clearly 
understood.  Most  important among these was  the kind and  dosage of 
vitamin C, optimal results being obtained only with optimal doses of natural 
vitamin C.  While the reasons for the apparent differential activity of the 
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natural and synthetic product still remain obscure, it is of interest to note 
that Elmby and Warburg (6) reported similar discrepancies in antiscorbutic 
efficiency; moreover, Klodt and  Stieb (7) have recently drawn attention to 
the  different  stability  of the  two preparations  when  exposed to oxidative 
agencies.  Next in importance appeared to be the size of the infecting dose 
of virus which had to stand in a certain relation to the amount of ascorbic 
acid.  Analogous examples of such quantitative interdependence in chemo- 
therapeutic experiments between virus and drug have since been furnished 
by the  action  of prontosil  album  on  lymphogranuloma  infection  in  mice 
(Baer, 8) and the effect of trypaflavin on experimental psittacosis (Mauer, 9). 
Apart  from  such  considerations,  the  experimental  work,  at  this  stage, 
left us with certain definite questions that called for further investigation. 
Obviously, there was a  need, first, for determining whether the more viru- 
lent  and  more  invasive  RMV  strain  of virus  was equally  susceptible  to 
inactivation in vitro by vitamin C as was the Aycock strain.  In the second 
place,  it  became necessary  to  examine  systematically  the  possibilities  of 
influencing  favorably  by  vitamin  C  administration  the  course  of  polio- 
myelitic  infection,  induced  either  by  introducing  large  amounts  of  this 
highly virulent strain into the nasal portal of entry or by injecting small and 
carefully gauged doses of this virus by the intracerebral  route.  It is the 
purpose of this communication  to present further results obtained in con- 
tinued tests along the lines indicated above. 
Methods 
The RMV strain of virus was used exclusively in this work.  Rhesus  monkeys weigh- 
ing from 2000 to 3000 gin. were infected either intranasally  or intracerebrally. 
All nasal infections were accomplished by instilling 1 cc. of a centrifuged 5 per cent 
suspension of virus into each nostril and repeating this procedure 4 hours later.  It was 
soon recognized that,  unless carefully  controlled for details  of technique,  intranasal 
instillation  may produce widely differing results in the infected animal.  When virus 
suspensions were prepared from cords not older than 2 weeks and, following light cen- 
trifugation, the thick supernatant  fluid, with tissue shreds, was squirted into the nostrils 
by pressure from a pipette armed with a rubber bulb, forcing the liquid forth and~back 
repeatedly, practically all of the infected monkeys developed within 5 to 7 days a rapidly 
progressing typical paralysis which terminated  in complete prostration  of the animal. 
However, when suspensions were made from cords in glycerin for about 4 weeks, and a 
thin  opalescent fluid, obtained after prolonged centrifugation, was simply allowed to 
drip into the nostrils, without  exerting any pressure, a variable percentage of the in- 
fected animals developed complete or partial paralysis of the extremities, the remainder 
showing various degrees of facial paresis, often transitory,  with weakness of the limbs, 
or no distinct paralytic symptoms at all.  Monkeys that failed to develop characteristic 
paralysis of the extremities, but showed weakness and facial involvement, passed through 
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normal, indicating that such episodes should be interpreted as "abortive takes" rather 
than as "missed cases."  Both methods of nasal infection were used in our work; in the 
protocols the respective modes of instillation are designated either as "pressure method" 
or as "droplet method." 
Concerning the intracerebral infection, it is sufficient to state that the technique was 
uniform throughout and identical with that previously followed, i.e. amounts of virus 
ranging from 1 cc. of a 1:100 to 1 cc. of a 1:200 dilution (0.01 cc. to 0.005 cc.) of the 
supernatant of a centrifuged 5 per cent cord suspension were injected into the frontal 
lobe of the brain. 
Two different preparations of vitamin C were used, i.e. either synthetic crystalline 
/-ascorbic  acid  (Merck)  or crystalline /-ascorbic  acid extracted from natural sources 
(Merck) .1  The natural product was of the same batches that had been employed in our 
previous work; however, this substance,  in the course of time, apparently had undergone 
profound chemical alteration (oxidation ?) as suggested by a yellow discoloration  of the 
originally snow-white  powder.  Unfortunately, no natural vitamin C  of reliable  and 
uniform composition can be obtained, at present, in quantities from any of the chemical 
or pharmaceutical manufacturers. 
The  in  Vitro  Inactivation  of the  RMV  Strain  of Poliomyelitis  Virus  by 
Vitamin C and by Hydrogen Peroxide 
In studying the power of chemical agents to inactivate the virus in vitro, 
the possibility must be excluded that inactivation, if and when it occurs, is 
not caused by acid destruction.  According to previous observations  (1), 
the virus of poliomyelitis remains active over a  wide range of pH values, 
extending from about 4.4  to  8.2.  In  our earlier work,  the  ascorbic  acid 
solutions, before being brought in contact with the virus, were adjusted to 
a pH of 6.6-6.8, which definitely eliminated the chance of acid inactivation. 
A  lower pH value of 5.2-5.3 was chosen deliberately in the present experi- 
ments so as to provide more favorable conditions for protecting the ascorbic 
acid  against  irreversible oxidation.  This  necessitated  a  preliminary  test 
in order to determine whether the virus, when exposed to a  pH of 5.2-5.3 
for a  period of about  18 hours, would fully retain its virulence.  The first 
experiment was carried out to answer this question. 
Experiment/.--Decreasing amounts of the supernatant of a 5 per cent centrifuged 
cord suspension  (0.1 cc. undiluted; 0.1 cc. of a  1:2 dilution; 0.1 cc. of a 1:10 dilution) 
were combined with  1 cc. of St}rensen's phosphate buffer of pH 5.28.  Control tubes 
containing the same amounts of virus with saline accompanied the experiment.  The 
mixtures were held for 1½ hours at 37°C. and overnight in the ice box; the total volume 
was  then injected intracerebrally into individual monkeys.  The results are recorded 
in Table I. 
1 We are indebted to Merck and  Company for placing at  our disposal  generous 
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As can be seen from Table I, all monkeys developed complete paralysis 
within from 5 to 7 days, indicating that amounts of virus ranging from 0.1 
cc. to 0.01 cc. had remained fully viable, under the conditions of  this test, 
at  a  pH range from 5.2  to 5.8. 
Experiment  2.--In this experiment a constant amount of virus, i.e. 0.1 cc. of a 1:10 
dilution of the supernatant of a centrifuged 5 per cent cord suspension, was combined 
with decreasing doses of synthetic vitamin C, varying from 50 mg. to 0.5 mg.  These 
doses were always contained in a volume of i cc. and were obtained by progressive dilu- 
tion with distilled  water of a freshly prepared 0.5 per cent mother solution of synthetic 
crystalline/-ascorbic acid which had been adjusted at pH 5.25 by the addition of suitable 
amounts of normal and N/10  sodium hydroxide.  Control tubes containing the same 
TABLE  I 
Effect of Phosphate Buffer pH 5.28 on the Viability  of Virus 
Monkey 
No. 
Chemical and pH 
Phosphate buffer pH 5.28 
c¢  cc  c~  Lc 
Salt solution 
~t  c~ 
Virus 
0.i 
0.05 
0.01 
0.01 
0.1 
0.05 
0.01 
Result 
Complete paralysis 6 days 
cc  ¢c  5  ~c 
"  "  6  " 
"  "  5  " 
"  "  7  " 
amount of virus, but mixed with acidulated distilled water at pH 5.2, accompanied this 
test.  After incubation for 1½ hours at 37°C. and stay in the ice box overnight the mix- 
tures were injected intracerebrally into individual monkeys.  The pH values of these 
mixtures had previously been checked following incubation and, again, before injection 
by colorimetric and electrometric readings.  The results are recorded in Table II. 
It will be seen from Table II that all of the monkeys receiving the vitamin 
C-virus mixtures remained free from paralytic symptoms while both control 
monkeys injected with  the  virus-distilled  water mixtures  developed com- 
plete  paralysis  on  the  7th  and  8th  day,  respectively.  This  experiment 
therefore confirms our previous observation that small amounts of vitamin 
C suffice to inactivate multiple paralytic doses of poliomyelitis virus in vitro. 
It  appears  further that  this phenomenon may be obtained with a  highly 
virulent strain of virus (RMV strain)  as well as with a  strain of moderate 
virulence (Aycock strain), using synthetic ascorbic acid  as weU as ascorbic 
acid  extracted from natural  sources. 
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be a possible factor in susceptibility to poliomyelitis, it seemed of interest 
to investigate whether the water-soluble vitamins of the B  complex also 
possess virucidal power.  In repeated tests it was found that neither B1 
(thiamin chloride) nor B~  (riboflavin), when mixed with the virus under 
similar  conditions,  brought  about  inactivation  of  the  infectious  agent. 
Negative  results were also obtained with nicotinic acid and with gluta- 
thione.  It appears therefore that the inactivation of poliomyelitis virus 
TABLE  II 
Inactivation of Virus in Vitro by Synthetic Ascorbic Acid 
Monkey  Vitamin C  No. 
mg. 
8  0.5 
9  0.5 
10  1 
11  1 
12  5 
13  5 
14  25 
15  25 
16  50 
17  50 
18  Salt solution 
19  "  " 
Virus 
GC. 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
p t ofmix- 
are after 
i]cubstion 
5.37 
5.37 
5.19 
5.19 
5.13 
5.13 
511 
5.1 
5.1 
5.1 
5.4 
5.4 
pH of mix- 
ture before 
injection 
5.2 
5.2 
5.28 
5.28 
5.4 
5.4 
5.32 
5.32 
5.23 
5.23 
5.6 
5.6 
Result 
No paralysis 
¢~  LC 
~f  fL 
L|  L~ 
LI  ~| 
~L  fC 
Complete paralysis 8 days 
~c  cc  7  ~¢ 
by ascorbic acid, within the limits of our tests, exhibits a certain degree of 
chemical specificity. 
The chemical forces that lead to inactivation of the virus by vitamin C 
are  not known.  However,  some light has  been  thrown on  the possible 
mechanism of the reaction by the work of Lojkin (11) who studied in great 
detail various phases of the inactivation of crystalline tobacco mosaic virus 
by/-ascorbic acid.  According to this author, the inactivation that occurs 
in vitamin C-virus systems is neither due to the reduced ascorbic acid nor 
to the irreversibly oxidized dehydroascorbic acid, but rather to the action 
of a  specific intermediate product which is formed in  the  course of the 
catalytic  auto-oxidation of  ascorbic  acid  under  the  influence of  copper 
ions; evidence is adduced to suggest that this product is a peroxide.  Sim- 320  VITAMIN  C  THERAPY  IN POLIOMYELITIS 
ilarly, Kligler and Guggenheim (12), in studying the detoxication of tetanus 
toxin by ascorbic acid, arrive at the conclusion that oxidation is an essential 
part  of the reaction which  serves to destroy both toxin and vitamin.  It 
is  generally accepted  that  poliomyelitis virus  is  peculiarly  susceptible  to 
the action of certain oxidizing agents, such as hydrogen peroxide, potassium 
permanganate, chlorine and ultraviolet light  (13); quantitative  data,  how- 
ever,  on  the  virucidal  effect of hydrogen peroxide  are  incomplete.  This 
prompted us to determine more accurately the end point of antiviral effi- 
ciency  of  hydrogen  peroxide  on  the  strain  of  virus  under  investigation. 
TABLE III 
Inactivation  of Virus in  Vitro by Hydrogen Peroxide 
Monkey No.  H20~ dilutions  Virus 0.5 ec.  Result 
0.5 cc. 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
1:100 
1:250 
1:500 
1:100 
1:500 
1:1000 
1:2500 
1:5000 
Control 
*c 
1 : 10 dilution (0.05) 
cc  c~  ~c 
1 : 50 dilution (0.01) 
1:10  dilution (0.05) 
1  : 50 dilution (0.01) 
No paralysis 
Slight paresis 10 days 
Complete paralysis 8 days 
No paralysis 
c*  *c 
Slight paresis 12 days 
Complete paralysis 7 days 
"  "  9  " 
Experiment &--Equal parts, i.e. 0.5 cc. of the supernatant of a 5 per cent centrifuged 
cord suspension,  diluted 1:10 or 1:50,  and 0.5 cc. of progressive  dilutions  of hydrogen 
peroxide (superoxol Merck =  about 30 per cent H202 by weight) were combined and the 
mixtures held for 1½ hours at 37°C.  Control tubes containing mixtures of virus and 
distilled  water were set up at the same time.  After stay in the ice box overnight these 
mixtures were then injected intracerebrally into individual monkeys.  The results are 
given in Table III. 
It  will  be  gathered  from Table  III  that  whereas  a  1:2500  dilution  of 
hydrogen  peroxide  is  sufficient  to  bring  about  complete  inactivation  of 
0.01  cc. of virus,  an amount 25  times stronger, to wit a  1:100  dilution of 
hydrogen  peroxide,  is  necessary  to  insure  complete  inactivation  of  an 
amount of virus 5 times larger, i.e. 0.05 cc.  While the virus of poliomyelitis 
is  therefore  readily  inactivated  by  hydrogen  peroxide,  no  simple  linear CLAUS  W.  JUNGEBLUT  321 
correlation seems to exist between the amounts of peroxide and the amounts 
of virus that must react so as to produce complete inactivation of the in- 
fectious agent.  As a matter of fact, a concentration of hydrogen peroxide 
fivefold that required by the law of multiple proportions was necessary in 
our tests to compensate for a  corresponding increase in the dose of virus. 
The Effect of Vitamin C Administration in Monkeys Infected Nasally with the 
RMV Strain of Virus 
A total of six different series were run.  Each series comprised a number 
of animals that had received daily subcutaneous injections of either natural 
or synthetic vitamin C, beginning with the day of infection, and an ade- 
quate number of untreated controls.  A wide range of vitamin C dosage 
was covered, including much larger amounts than had been used in our 
previous work.  This was done, partly with the view of augmenting the 
chances for a therapeutic effect against the more virulent strain of virus and 
partly in the hope of being able to compensate for any possible  inferior 
effectiveness of the synthetic product.  The ascorbic acid solutions were 
adjusted to a pH of between 5 and 6 shortly before administration to avoid 
any tissue ulceration at the site of injection.  In three of these six series 
the pressure method of intranasal instillation was used and in three the drop- 
let method, both methods having been described in detail elsewhere in this 
paper.  The protocols of the individual series and a summary of the results 
obtained with the two different methods of nasal infection are presented in 
Table IV. 
It is clear from an inspection of Table IV that in three series in which an 
infection of maximum severity was produced by flooding the nasal portal 
of entry with huge amounts of virus, vitamin C administration, irrespective 
of the kind and amount of ascorbic acid used, failed singularly to exert any 
influence on the course of the disease.  Thus, with the exception of one 
non-paralyzed survivor among a total of 50 treated animals and one surviv- 
ing animal with facial paralysis among a total of 20 controls, all monkeys 
developed complete and  prostrating  paralysis  within  about  one  week's 
incubation period. 
Somewhat different results were obtained in the three series with a less 
drastic  mode  of infection.  Not  only was  the  disease  produced by  the 
droplet method of instillation much less severe than that induced by the 
pressure method, but the symptoms became progressively lighter from series 
to series in both groups of animals, treated and untreated.  Undoubtedly, 
the droplet instillation created conditions under which only minute amounts 
of virus reached the olfactory area, allowing for a variable number of ani- 322  VITAMIN  C  THERAPY  IN  POLIOMYELITIS 
mals to develop typical paralysis of the extremities while the remainder 
showed either slight transitory involvement of the central nervous system 
or escaped paralysis entirely.  As one would expect, the margin of differ- 
TABLE  IV 
Effect of Vitamin C Treatment in Monkeys Infected Intranasally 
Series 
II 
III 
I-III 
(total) 
IV 
V 
VI 
IV-VI 
(total) 
Monkeys 
C-treated 30 
Controls  10 
C-treated 15 
Controls  5 
C-treated  5 
Controls  5 
C-treated 50 
Controls  20 
c-treated 28 
Controls  5 
C-treated 18 
Controls  10 
C-treated I0 
Controls  5 
d Daily 
osage  of 
Method  of  vitamin 
nasal instilla-  C  (natu- 
tion  ral or 
syn- 
thetic) 
~'lg. 
Pressure  10-100 
c~ 
ct 
ct 
~c 
t~ 
it 
C-treated 56 
Controls  20 
29 
10 
150-50~  15 
--  5 
500  5 
--  4 
Result 
Complete 
Imratys~s 
49 (98%) 
19 (95%) 
Droplet  100-300  20 
"  --  4 
"  100-300  2 
tt  --  :  2 
"  150-400  0 
"  22 
"  7 
(39.3%) 
(35%) 
Partial 
paralysis 
0 
1" 
o (0%) 
1 (5%) 
0 
1" 
1 
st 
0 
2* 
1 (1.8%) 
8 (40%) 
No paralysis 
1 (2%) 
0 (0%) 
15 
3 
10 
2 
33 (59%) 
5 (25%) 
* Animals marked thus showed only facial paralysis with weakness  of limbs. 
t  Of the 5 animals in this group, 1 monkey developed only facial paralysis with weak- 
ness of limbs, the remaining four showing distinct partial paralysis of the extremities. 
ence between the  severity of the experimental infection in the treated ani- 
mals and the controls,  though favoring the  treated animals consistently in 
every  series,  became  more pronounced  with  the  lighter  infections.  This 
may simply mean that the chances increased for the conversion of abortive 
infections  into  the  complete  suppression  of paralytic  symptoms although 
the  comparatively small number of experimental animals makes a  proper 
interpretation  of  such  borderline  results  very  difficult.  When  the  data CLAUS  W.  JUNGEBLUT  323 
for the last three series are taken as a whole, it will be found that among a 
total of 56 C-treated animals there were 23  (41 per cent)  that developed 
complete or partial paralysis  of  the  extremities while  33  (59  per  cent) 
showed no paralytic symptoms whatsoever; among a  total of 20 controls, 
on the other hand, there were 11 (55 per cent) that developed complete or 
partial  paralysis  of  the  extremities,  4  (20  per  cent)  that  showed facial 
paresis with weakness of the limbs and 5 (25 per cent) that escaped paralysis 
altogether.  The percentage of monkeys developing severe paralysis was 
therefore hardly significantly reduced in the treated group as compared with 
the non-treated group  (41  per cent against 55  per cent); however, it  is 
clear that the percentage of monkeys that remained objectively free from 
any paralytic symptoms was about twice as high in the treated animals as 
in the untreated controls (59 per cent against 25 per cent). 
The Effect of Vitamin C Administration in Monkeys Infected Intracerebrally 
with the RMV Strain of Virus 
In view of the limited success obtained in the experiments listed above 
in which C administration was begun on the day of infection, it was thought 
advisable to prepare monkeys by daily injections of large doses of ascorbic 
acid over a period of 2 weeks and then to continue treatment from the day 
of infection with smaller amounts.  A total of five different series were run, 
each  series  comprising a  variable  number of  C-treated  animals  and  an 
adequate number of controls that remained untreated.  The infecting dose 
of virus varied from 0.01  ce.  to 0.005  co., injected intracerebrally.  Only 
synthetic vitamin C was used in these tests.  The results have been brought 
together in Table V. 
It appears from Table V that all 20 control animals, without exception, 
developed paralysis of various degrees within the first 2  weeks following 
infection; among a  total of 30  C-treated animals, on the other hand,  22 
showed typical paralysis, 3 developed the disease after definitely prolonged 
incubation periods (15 to 18 days), and 5 remained entirely free from par- 
alytic symptoms.  As might have been predicted, the greater number of 
non-paralytic survivors was observed in  the group of monkeys infected 
with the smaller amount of virus, i.e. 0.005 cc.  Taking the data as a whole 
it follows, therefore, that the percentage of monkeys developing prostrating 
paralysis was only slightly lower in the treated group than in the control 
group (66 per cent against 75 per cent); however it is evident that C treat- 
ment served to change appreciably the proportion between partially par- 
alyzed animals and those that remained objectively free from any paralytic 
symptoms.  In other words, whereas none of the controls failed to exhibit 324  VITAMIN  C  THERAPY  IN  POLIOMYELITIS 
some degree of paralysis, fully 16 per cent of the treated animals showed no 
evidence whatsoever of any paralytic involvement.  This difference is fur- 
ther paralleled by the regular occurrence of a definite fever cycle in all of 
the partially paralyzed controls as contrasted with the completely afebrile 
course in the non-paralytic treated animals (see Chart 1). 
TABLE  V 
E~ect ~  Vitamin C Treatment in Monkeys Infected Intracerebral~ 
Num. i  Dose l 
I  Dosage of  vitamin C  Type of  berof  of  I 
animal  ani-  virus  (synthetic)  I  mals 
£g, 
,'-prepared  12  0.01 
~ontrols  7 
~-prepared  18 
0.01 
;ontrols  13  •  0.005__ 
,'-prepared  30 
(total) 
,'ontrols  20 
(total) 
300 rag. daily for 
14 days before 
infection, and 
continued after 
infection 
0.005  300 rag. daily for 
14 days before 
infection; 100 
rag. daily after 
infection 
Result 
Typical  paralysis 
(incubation  period  up to 
14 days) 
Complete  Partial 
paralysis  paralysis 
11  0 
7  0 
9  2 
8  5 
20 (66.6%)  2 (6.6%) 
15 (75%)  5 (25%) 
Atypical 
paralysis 
(incubation 
period  over 
14  days) 
0 
0 
3 
0 
No paralysis 
3 (10%)  5 (16.6%1 
0 (0%)  0 (0%) 
In summarizing the experimental data, one would feel justified in con- 
cluding that, under the conditions of our tests, prophylactic and therapeutic 
administration of synthetic ascorbic adid has given evidence of being capable 
of modifying the course of the disease.  However, it is clear that the results 
were not nearly as striking as previously reported with optimal doses of 
natural vitamin  C  in monkeys infected intracerebrally with the Aycock 
strain of virus.  As a  matter of fact, in spite of using larger amounts of 
ascorbic  acid  and  combining prophylactic preparation  with  therapeutic 
administration, the percentage of non-paralytic survivors in this study did 
not differ materially from the figure obtained in previous work with the 
synthetic compound (16 per cent against 10 per cent). __>d~ 
~  ,.,..,~ 
:..,,,~.F'  ,~  .  :  I 
,<  ~,.  .... 
........  ,~  ~.~.....~ 
~..21.""  ~. ~  " ....  ~,  --" 
~  "'~ ~ ~.  .... >~ ?  ~... 
~-'  ~o,  ,  ~  ~  1:1  ~  ~  ~  ~o~,~ 
°~  o  '~  ~o~  ~  Z~  ~  °  ~°~ ~  ~  ~  ~~  ~  z  ~_~-~  ~  z  ~ 
~.  ~  o~  ~  :"  ~  ~  8  ~n  ~  o  ~.z~ 
~,~  ~,~  ~  o  ~  ~  "'~8  ~, 
I 
~.'"  ~  ~ 
_.~-"  .° 
I 
~  .,.,,  ~  ~  .:.  o 
~  ~ :':.,  ~.( ....  .~ 
-.  ~ 
•  ":  ~  Z  • 
•  ,  ..  ,  .. 
325 326  VITAMIN  C  THERAPY  IN POLIOMYELITIS 
It has seemed of interest to submit the cords of paralyzed monkeys to 
careful histological examination so as to compare the extent and type of the 
lesions in the control animals with those of monkeys which had received 
vitamin C, even though treatment had obviously failed to prevent paralysis. 
In the majority of the cases we found the pathological process in the cords 
of the C-treated animals to  differ distinctly from that presented by un- 
treated controls.  This difference concerned more the type of cellular re- 
action  than  the  extent  of  its  involvement.  While  the  controls  showed 
uniformly severe  nerve  cell  destruction,  with  fully  developed polymor- 
phonuclear invasion  and  neuronophagia, as  well  as  intensive interstitial 
cellular response, the lesions in the ganglion cells of C-treated animals were 
characterized by a good deal of chromatolysis, but rarely was cell degenera- 
tion complete and the degree of microglial proliferation and lymphocytic 
infiltration appeared decidedly less marked.  Moreover, the lining of the 
central canal was better preserved in the latter, with more regular spacing 
and less crowding of the ependymal cells.  In addition, we have often ob- 
served neuronal shrinkage and open perineural spaces, resulting in pictures 
which recall the type of cellular reaction described by Altmann (14) in the 
central nervous system of dogs that had been injected with large amounts of 
ascorbic acid.  It is not certain whether the latter reaction served, in part, 
to protect the nerve cells against more extensive damage from the virus; 
however  to  postulate  an  anti-edematous  effect  of  ascorbic  acid  in  the 
affected areas  would not be inconsistent with the accepted physiological 
function of the vitamin. 
The described differences will  readily  become  apparent from a  study 
of Figs.  1 to  10 which represent typical fields of cord sections, cut from 
similar levels, of either C-treated or control animals. 
DISCUSSION 
The results recorded in this paper serve to affirm and extend our previous 
observations on the effect of crystalline vitamin C  on poliomyelitis virus. 
They deafly show that small amounts of ascorbic acid, either natural or 
synthetic, are capable of inactivating in vilro  multiple paralytic doses of 
two  different strains  of this virus.  This virucidal action of vitamin C, 
however,  is  by  no  means limited to  poliomyelitis virus.  Thus,  several 
other animal  and plant  viruses,  i.e.  vaccinia virus,  herpes virus,  rabies 
virus, foot and mouth disease virus, tobacco mosaic virus, and even bacte- 
riophage, are also inactivated by this substance (15), as are a  number of 
bacterial toxins, including diphtheria, tetanus, dysentery, staphylococcus, 
and anaerobic toxins (16).  On the other hand,  such antiviral effects so CLAUS  W.  JUNGEBLUT  327 
far  have not been obtained with any vitamin other than  ascorbic  acid, 
excepting the possible action of vitamin D on poliomyelitis virus (Toomey, 
17).  Vitamin C, therefore, may truthfully be designated as the "antitoxic 
and  antiviral"  vitamin. 
There are reasons for believing that the inactivation occurring in virus- 
vitamin C systems is brought about by oxidation through some peroxide. 
This assumption finds support in our observation that poliomyelitis virus, 
like tobacco mosaic virus  (18),  diphtheria toxin  (19),  and tetanus toxin 
(20), is highly vulnerable to the action of hydrogen peroxide.  This exqui- 
site susceptibility to oxidizing agents stands in marked contrast to the re- 
markable resistance of the same viruses and toxins to protoplasmic poisons, 
such as phenol for instance, and serves to emphasize the similarity that 
seems to exist between viruses, toxins, and enzymes, as a group, when com- 
paring their reaction to  certain chemicals with those of living agents of 
disease. 
When we come to examine the experimental evidence that vitamin C may 
act as an antiviral agent in the infected animal, the data, at first sight, are 
not very encouraging.  Thus, Holden and Molloy (21) failed to observe any 
therapeutic effect from the administration of ascorbic acid to rabbits in- 
fected with  herpes virus;  similarly,  Langenbeck and  Enderling  (22)  re- 
ported negative results with ascorbic acid treatment of guinea pigs suffer- 
ing  from  experimentally produced foot  and  mouth  disease.  As  far  as 
poliomyelitis is  concerned, it  seems safe to  state  that,  under certain re- 
stricted experimental conditions, suggestive evidence is on hand to show 
that vitamin C is capable of influencing favorably the course of the infection 
in monkeys.  However, this effect is comparatively slight and limited by 
a number of factors many of which are not yet under experimental control. 
Most important among these is probably the size of the infecting dose of 
virus.  When the intranasal route is chosen, infection with quantitatively 
graded  doses is  frankly  impossible.  Huge  amounts of virus  suspension 
must be forced up the nasal passages to ensure the occurrence of paralysis 
with any degree of regularity and it remains undetermined whether the 
olfactory neuron has made contact with one or with multiple paralytic doses. 
As a  matter of fact, simple calculation of the amounts involved suggests 
that,  even though most of the instilled fluid is  swallowed, enough must 
remain to represent an actual infecting dose which is many times larger 
than the minimum amount of virus which will regularly produce paralysis 
upon intracerebral inoculation.  It is therefore not surprising that vitamin 
C treatment of monkeys infected by the nasal route should have failed to 
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the same severe method of intranasal instillation was employed.  With a 
less drastic method of intranasal instillation, on the other hand, in which 
only threshold amounts of virus reach the olfactory fibers, the picture of 
the disease in control animals becomes so variable that the results do not 
lend themselves to unequivocal interpretation; but the impression is gained 
that treated animals stand a  better chance of converting abortive attacks 
into  an  altogether  non-paralytic  course.  Nevertheless,  it  has  not  been 
possible  to  duplicate the seemingly startling results obtained in two pre- 
liminary experimental series with nasal infection (3).  The reasons for this 
discrepancy can only be conjectured; presumably a combination of factors, 
such as irregularities inherent in the mode of nasal instillation and fluctua- 
tions in virulence of the virus provided conditions under which vitamin C 
appeared to act more favorably on the course of the infection than can be 
substantiated by repeated tests. 
When the same strain of virus is used to infect monkeys by the intra- 
cerebral route, a definite range of minimal doses can be found which results 
in  the production of paralysis with a  high degree of certainty.  Control 
animals  injected with  such  amounts  (0.01  to  0.005  cc.)  show but  little 
individual difference in response to the virus as indicated by the uniformity 
of the preparalytic fever curve, the fixed incubation period, and the severe 
and generalized paralysis;  with the  smaller doses of virus,  however, the 
extent  of  central  nervous  system  involvement is  somewhat  variable  as 
shown by the occasional recovery of a monkey following isolated paralysis 
in one or several limbs.  This pattern of the experimental disease in control 
animals  appears  to  be  significantly changed in  monkeys which have re- 
ceived vitamin C, the latter animals showing signs of individual variation 
in response which are not observed in untreated controls.  This variation 
may either take the form of prolonged incubation periods, or lead to the 
evolution of a  completely afebrile course without any objective paralytic 
symptoms; but there is no reduction in the extent and severity of paralysis, 
once vitamin C has failed to prevent its onset.  It would rather seem as if 
the fate of the infected animal which receives vitamin C is determined by a 
critical equilibrium of several component factors which, in their totality, 
tend to interfere with virus propagation; hence, ascorbic acid may do noth- 
ing more than tip the balance in favor of a successful outcome by increasing 
the forces of natural resistance.  Certainly, the therapeutic or preventive 
action of this substance is too limited, irregular, and complex to permit one 
to regard it in any sense as a true chemotherapeutic agent in experimental 
poliomyelitis.  However, it  is conceivable that  its action may be comple- 
mented by  the introduction  of other physiological factors,  which would CLAUS  W.  JUNGEBLUT  329 
tend to augment its effect, such as metal ions, other vitamins and hormones, 
or immune serum; or, that ascorbic acid, because of its basic biochemical 
properties,  may  ultimately  become  the  mother  substance  that  would 
yield more powerful antiviral agents of true chemotherapeutic character. 
One may ask with good reasons what bearing the foregoing experimental 
data have on the rationale of using ascorbic acid in the prophylaxis land 
therapy of the human disease.  An answer is not easily provided since the 
factors which permit natural infection in the susceptible child are not re- 
flected in the animal experiment.  Certain it is, that the monkey does not 
exhibit that degree of susceptibility which characterizes human predisposi- 
tion.  The point that appears crucial for any prognostication  is whether 
or not the selective human susceptibility to the disease is related fundamen- 
tally to  C  metabolism.  With any convincing evidence to  that  effect we 
would seem to be on more hopeful ground.  For there are many examples 
to  show that  vitamin  administration will  restore deficient individuals to 
normal levels of defense; but whether a  superabundance of vitamin C  can 
enhance adequate function to hypernormal efficiency is by no means cer- 
tain  (23).  In this connection the extensive observations of Heaslip  (24) 
anent a  recent epidemic of poliomyelitis in  South Australia are of great 
interest.  In estimating the urinary output of vitamin C, under a load test, 
a mean figure of 19.9 per cent excretion was obtained in 60 cases of polio- 
myelitis as contrasted with a mean figure of 44.3 per cent in 45 healthy con- 
tacts, suggesting some relationship between the degree of vitamin C satur- 
ation and the infectious and non-infectious state.  A correlation was further 
shown to exist between the severity of the attack and the level of urinary 
excretion of the vitamin; moreover, comparing the severity of the disease 
and urinary excretion of vitamin  C  among urban  and rural cases it  was 
found that the distribution of cases corresponded with the facts collected 
in a previous nutritional survey on the state of nutrition in urban and rural 
populations.  A study of the geographical spread of the epidemic in several 
Australian States finally suggested some relationship between the incidence 
of the disease, its age distribution, and the known facts regarding the nu- 
tritional state of the respective populations.  On the basis of these findings 
Heaslip states that the associated phenomena remain unexplained unless 
the assumption is made that the vitamin deficiency preceded the disease 
and concludes "that a low level of vitamin C nutrition predisposes  to in- 
fection and severity of attack." 
SU-MMARY AND  CONCLUSIONS 
1.  Multiple paralytic doses of poliomyelitis virus  (RMV strain),  when 
brought  together with  small amounts of synthetic ascorbic acid in vitro, 330  VITAMIN C THERAPY IN  POLIOMYELITIS 
are rendered non-infectious as determined by intracerebral injection of such 
mixtures into rhesus  monkeys. 
2.  Vitamin C administration to monkeys infected intranasally with the 
RMV strain produces results which differ in accordance with the technique 
employed for nasal instillation.  With an infection of maximum severity, 
induced by flooding the nasal portal of entry with large amounts of virus, 
vitamin C administration fails to exert any demonstrable influence on the 
course of the disease.  With a less forceful method of droplet instillation, 
the picture of the disease in control animals becomes so variable that the 
results cannot be easily interpreted; but the available data suggest that 
vitamin C treatment may be a factor in converting abortive attacks into an 
altogether non-paralytic infection. 
3.  The administration of synthetic vitamin C to monkeys infected intra- 
cerebrally with small doses of the RMV strain gives results comparable to 
those previously obtained with this substance in monkeys infected intra- 
cerebrally with the Aycock strain of poliomyelitis virus. 
4.  The implications of the findings are discussed. 
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EXPLANATION OF PLATE 33 
FIGS. 1 to 4.  Sections  of various levels of the cords of  untreated  paralyzed  con- 
trol monkeys. 
Fit.  5.  Central canal of a paralyzed control monkey. 
FIGs.  6  to  9.  Sections  of  various  levels  of  the  cords  of  C-treated  paralyzed 
monkeys. 
Fit.  10.  Central canal of a  C-treated paralyzed monkey. 
Note the difference in the degeneration  of  nerve  cells and  the  extent  of  the  in- 
flammatory  reaction  between  untreated  controls  and  C-treated  animals;  also  the 
difference in the degree of  edema  shown  by  the  alignment  of  the  ependymal cells 
of the central canal in the two groups of animals. THE JOURNAL  OF  EXPERIMENTAL  MEDICINE VOL. 70  PLATE 33 
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